177 Screening practices for cystic fibrosis related diabetes (CFRD) in the UK
نویسندگان
چکیده
منابع مشابه
The use of fructosamine in cystic fibrosis-related diabetes (CFRD) screening.
OBJECTIVE To determine whether serum fructosamine correlates with glycemic control and clinical outcomes in patients being screened for cystic fibrosis-related diabetes (CFRD). METHODS Fructosamine and percent predicted forced expiratory volume in 1s (FEV1) were measured in patients undergoing a 2h oral glucose tolerance test (OGTT) for CFRD screening. Fractional serum fructosamine (FSF) was ...
متن کاملCystic Fibrosis-Related Diabetes: Screening and Diagnosis
CFRD — Cystic fibrosis-related diabetes — is the most prevalent extrapulmonary complication of cystic fibrosis and is associated with decline in pulmonary function, poor nutritional status, and greater mortality. Although our general understanding of CFRD has increased, difficult areas remain in its pathophysiology, screening, diagnosis, and management that require further research and developm...
متن کاملUpdate on diagnosis and monitoring of cystic fibrosis-related diabetes mellitus (CFRD).
Cystic fibrosis (CF) is the most common recessive autosomal disease among Caucasian. Children with CF have benefitted from advances in medical and nutritional treatments, and this can be gleaned from the improvement in the survival of these patients. The increase in the survival rate brought with it the appearance of co-morbidities related to CF. Nowadays cystic fibrosis-related diabetes (CFRD)...
متن کاملScreening for cystic fibrosis-related diabetes: a systematic review.
BACKGROUND Cystic fibrosis (CF) is an inherited disease that leads to damage to lungs, pancreas and other organs. Most people with CF die prematurely from lung disease, but survival has improved markedly over the decades and it is estimated that children born with CF now will live to an average age of 50 years. CF-related diabetes (CFRD) is due to damage to the pancreas, which, over time, loses...
متن کاملImproving screening for cystic fibrosis-related diabetes at a pediatric cystic fibrosis program.
OBJECTIVE Despite guidelines recommending an annual oral glucose tolerance test (OGTT) for all patients with cystic fibrosis (CF) aged ≥ 10 years, screening rates for cystic fibrosis-related diabetes (CFRD) remained low at our center. The aim of this project was to implement an outpatient system to provide effective, evidence-based screening for CFRD at a pediatric CF program. METHODS Develop...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cystic Fibrosis
سال: 2016
ISSN: 1569-1993
DOI: 10.1016/s1569-1993(16)30415-5